Avagliano Mark

CIK 00017835031 companyRESEARCH TRIANGLE PARK, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001783503

Recent Transactions

24 trades

Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−89,400→ 0 total
Disposition from Tender
G1 Therapeutics, Inc.
Common Stock
2024-09-18−26,035→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Common Stock
2024-09-18−236,610→ 26,035 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−41,100→ 0 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-09-18+20,600→ 262,645 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-07-05$2.51/sh−2,638→ 242,045 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-07-01+35,000→ 244,683 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-05-13$4.79/sh−8,151→ 209,683 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-03-20+100,000→ 217,834 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-04$2.94/sh−721→ 117,834 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-01-03+44,760→ 121,915 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−758→ 121,157 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2024-01-03+89,400→ 89,400 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−2,602→ 118,555 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-05-10+35,000→ 77,155 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2023-01-03+41,100→ 41,100 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-01-03+20,600→ 42,155 total
Sale
G1 Therapeutics, Inc.
Common Stock
2022-01-05$10.61/sh−1,445→ 21,555 total
Award
G1 Therapeutics, Inc.
Common Stock
2022-01-03+12,000→ 23,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2022-01-03+53,000→ 53,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-01-04+58,000→ 58,000 total
Award
G1 Therapeutics, Inc.
Common Stock
2021-01-04+11,000→ 11,000 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2020-02-06+60,000→ 60,000 total
Award
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2019-07-29+300,000→ 300,000 total

Companies

G1 Therapeutics, Inc.
Chief Business Officer

Recent Filings

Address

C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR. 4501 RESEARCH COMMONS, SUITE 100

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov